Role of 18F‐FDOPA PET/CT imaging in endocrinology

@article{Santhanam2014RoleO1,
  title={Role of 18F‐FDOPA PET/CT imaging in endocrinology},
  author={P. Santhanam and D. Ta{\"i}eb},
  journal={Clinical Endocrinology},
  year={2014},
  volume={81}
}
  • P. Santhanam, D. Taïeb
  • Published 2014
  • Medicine
  • Clinical Endocrinology
    • 18F‐FDOPA (6‐[18F]‐L‐fluoro‐L‐3, 4‐dihydroxyphenylalanine)‐based PET/CT imaging can be a useful tool for the detection of different neuroendocrine tumours (NETs). 18F‐FDOPA is taken up into the cells via the neutral amino acid transporter (LAT1/4F2hc). This transporter is also coupled to the mammalian target of rapamycin (mTOR) signalling pathway. 18F‐FDOPA PET/CT may be performed for confirmation of diagnosis of pheochromocytoma/paraganglioma, staging at initial presentation, restaging and… CONTINUE READING
    View on Wiley
    ncbi.nlm.nih.gov
    47 Citations
    Highly Influencial Citations
    3
    Background Citations
    14
    Methods Citations
    3
    47 Citations
    Citation Type

    Citation Type

    The current role of 18F-FDOPA PET for neuroendocrine tumor imaging
    • 7
    68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
    • 51
    • Highly Influenced
    Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
    • 1
    Adrenal tracer uptake by 18F-FDOPA PET/CT in patients with pheochromocytoma and controls
    • 3
    • PDF
    Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes
    • 2
    The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease
    The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.
    • 18
    18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
    Molecular imaging in the investigation of hypoglycaemic syndromes and their management.
    • 15
    • PDF
    Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism
    • 6
    • PDF

    References

    SHOWING 1-10 OF 108 REFERENCES
    18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours
    • 26
    PET/CT using 18F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting
    • 16
    18F-Fluorodihydroxyphenylalanine PET/CT in Patients with Neuroendocrine Tumors of Unknown Origin: Relation to Tumor Origin and Differentiation
    • 39
    • PDF
    Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer
    • 27
    A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma
    • 65
    Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
    • 95
    18F-DOPA positron emission tomography for the detection of glomus tumours
    • 156
    Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
    • 68
    • PDF
    Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma
    • 59
    • PDF
    Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
    • D. Putzer, M. Gabriel, +6 authors I. Virgolini
    • Medicine
    • The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
    • 2010
    • 48